患者在肌缩性侧面硬化症中使用甲基可巴胺注射的经验
Adeel S Zubair1, Lea Saab1, Kirsten Scharer1
1Department of Neurology, School of Medicine, Yale University, New Haven, CT, USA.
Brain circulation
|April 24, 2024
概括
超高剂量的维生素B12注射对肌缩性侧面硬化症 (ALS) 患者提供潜在的好处,改善能量和减少疲劳. 需要进一步的研究来证实它对疾病进展和生活质量的影响.
科学领域:
- 神经学 神经学
- 营养科学 营养科学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,缺乏确定的治疗方法.
- 超高剂量的甲基可巴胺 (维生素B12) 被非标签用于ALS,证明了安全性和减缓功能衰退的潜力.
研究的目的:
- 评估维生素B12注射对5名ALS患者生活质量的影响.
- 探索患者和护理人员对维生素B12治疗的经验.
主要方法:
- 与ALS患者及其护理人员进行了半结构化采访.
- 数据分析涉及两个研究人员的独立编码和主题组织.
主要成果:
- 4个主要主题和11个子主题出现,涵盖患者情况,注射管理,主观经验和结果.
- 参与者报告了诸如增加能量,减少疲劳和改善平衡等益处.
- 由于ALS的进展性,患者有时难以分离维生素B12的特定作用.
结论:
- 维生素B12注射为运动能力和力量下降的ALS患者提供了灵活的治疗选择.
- 这项研究强调需要更多的随机对照试验,以澄清维生素B12对ALS进展,功能和生活质量的影响.
更多相关视频
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
60.8K
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
20.6K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
800
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
800